The Biology of Health Disparities: Ancestry-Driven Drug Discovery - K. Sean Kimbro

The Biology of Health Disparities: Ancestry-Driven Drug Discovery - K. Sean Kimbro

National Human Genome Research Institute via YouTube Direct link

- Introduction Julie Segre

1 of 33

1 of 33

- Introduction Julie Segre

Class Central Classrooms beta

YouTube videos curated by Class Central.

Classroom Contents

The Biology of Health Disparities: Ancestry-Driven Drug Discovery - K. Sean Kimbro

Automatically move to the next video in the Classroom when playback concludes

  1. 1 - Introduction Julie Segre
  2. 2 - Start of Presentation K. Sean Kimbro
  3. 3 - About North Carolina Central University
  4. 4 - Kimbro Lab
  5. 5 - Migration and Forced Migration
  6. 6 - Unnatural Selection
  7. 7 - American Descendants of Enslaved Africans ADEA
  8. 8 - Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer
  9. 9 - Signatures of Environmental Genetic Adaptation Pinpoint Pathogens as the Main Selective Through Human Evolution
  10. 10 - IRA and TLR3 Sequence Variants May Alter Breast Cancer Risk Among African American Women
  11. 11 - Research Papers
  12. 12 - What would it look like to design drugs from a different perspective?
  13. 13 - 2020 Drug Trials Snapshot Summary Report
  14. 14 - Share of world population by major regions
  15. 15 - Race-based Drugs BIDIL
  16. 16 - Ancestral-Driven Drug Discovery
  17. 17 - Ancestral characterization of 1018 cell lines highlights disparities and reveals gene expression and mutual differences
  18. 18 - Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines
  19. 19 - New Approach: Addressing the Biology of Health Disparities by Targeting Geographical
  20. 20 - Molecular Profiling and Ancestral Proportions Triple Negative Breast Cancer TNBC Cell Lines
  21. 21 - The neuroendocrine mechanisms of chronic stress
  22. 22 - IC50s with Norepinephrine
  23. 23 - Increased circulating cytokine levels in African American women with obesity and elevated HbA1c
  24. 24 - Importance of Targeting IL-4 and IL-13 receptors for cancer therapy
  25. 25 - IL4/IL4R-activated signaling pathways that promote growth phenotypes
  26. 26 - Linear Map of IL4R
  27. 27 - IL4R Variants of Interest
  28. 28 - Acknowledgements
  29. 29 - Q&A Session
  30. 30 - Prevalence of selected innate immunity sequence variants in TNBC cell lines
  31. 31 - AlphaFold outputs for IL4R wt and variants
  32. 32 - Goal
  33. 33 - Things to think about

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.